关注
Aaya Nassar
Aaya Nassar
在 sci.cu.edu.eg 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
A review of human coronaviruses’ receptors: the host-cell targets for the crown bearing viruses
A Nassar, IM Ibrahim, FG Amin, M Magdy, AM Elgharib, EB Azzam, ...
Molecules 26 (21), 6455, 2021
512021
In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
I Khater, A Nassar
Biochemistry and Biophysics Reports 27, 101032, 2021
292021
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
I Khater, A Nassar
BMC Pharmacology and Toxicology 23 (1), 91, 2022
72022
Repurposing antiviral drugs to inhibit SARS-CoV-2 Papin-like protease activity
I Khater, A Nassar
International Journal of Intelligent Computing and Information Sciences 21 …, 2021
22021
In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoids
FG Amin, AA Elfiky, AM Nassar
Journal of Biomolecular Structure and Dynamics 42 (2), 1079-1087, 2024
12024
A computational peptide model induces cancer cells’ apoptosis by docking Kringle 5 to GRP78
I Khater, A Nassar
BMC molecular and cell biology 24 (1), 25, 2023
12023
Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis
I Khater, A Nassar
Plos one 17 (5), e0268909, 2022
12022
Looking into mucormycosis coinfections in COVID-19 patients using computational analysis.
I Khater, A Nassar
AIMS Biophysics 9 (1), 2022
12022
SARS-CoV-2 variant surge and vaccine breakthrough infection: a computational analysis
I Khater, A Nassar
Informatics in medicine unlocked 29, 100873, 2022
12022
Targeting EGFR and VEGFR-2 Kinases With Nanoparticles: A Computational Approach for Cancer Therapy Advancement
I Khater, A Nassar
Cancer Investigation 42 (2), 176-185, 2024
2024
Potent Inhibitors for SARS-COV-2 Main Protease: An in-Silico Study for Drug Development
I Khater, A Nassar
Authorea Preprints, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–11